Story on FDA authorizing new test kit for coronavirus withdrawn

By Reuters Staff

FILE PHOTO: People wait in line to be tested for coronavirus disease (COVID-19) while wearing protective gear, outside Elmhurst Hospital Center in the Queens borough of New York City, U.S., March 30, 2020. REUTERS/Jeenah Moon

Reuters - The March 31 story on BodySphere receiving FDA authorization for a rapid antibody test for coronavirus has been withdrawn. In a statement to Reuters, BodySphere said it has not received this authorization. There will be no replacement story.

Our Standards: The Thomson Reuters Trust Principles.